{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:46:43Z","timestamp":1792608403685,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016623","name":"Radiation Oncology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cllc.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:26:02Z","timestamp":1724451962000},"page":"e459-e465.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Untapping the Prognostic Value of Patient-Generated Health Data in Locally Advanced Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-513X","authenticated-orcid":false,"given":"Nitin","family":"Ohri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bodner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhur","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Halmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalom","family":"Kalnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2024.08.010_bib0001","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3322\/caac.21608","article-title":"Innovations in research and clinical care using patient-generated health data","volume":"70","author":"Jim","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2024.08.010_bib0002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.3969","article-title":"Quality of life analysis of a radiation dose\u2013escalation study of patients with non\u2013small-cell lung cancer: a secondary analysis of the radiation therapy oncology group 0617 randomized clinical trial","volume":"2","author":"Movsas","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0003","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2019.07.055","article-title":"Daily step counts: a new prognostic factor in locally advanced non-small cell lung cancer?","volume":"105","author":"Ohri","year":"2019","journal-title":"Internat J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2024.08.010_bib0004","doi-asserted-by":"crossref","first-page":"dju244","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2024.08.010_bib0006","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1741-6612.2009.00372.x","article-title":"Physical activity of older Australians measured by pedometry","volume":"28","author":"Ewald","year":"2009","journal-title":"Australasian J Ageing"},{"key":"10.1016\/j.cllc.2024.08.010_bib0007","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijrobp.2017.10.032","article-title":"Positron emission tomography\u2013adjusted intensity modulated radiation therapy for locally advanced non-small cell lung cancer","volume":"102","author":"Ohri","year":"2018","journal-title":"Internat J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2024.08.010_bib0008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clinical Trials"},{"key":"10.1016\/j.cllc.2024.08.010_bib0009","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2024.08.010_bib0010","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non\u2013small-cell lung cancer: groupe lyon-saint-etienne d'oncologie thoracique\u2013groupe fran\u00e7ais de pneumo-canc\u00e9rologie NPC 95-01 study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0011","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0012","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1200\/JCO.2005.07.167","article-title":"Randomized trial of amifostine in locally advanced non\u2013small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01","volume":"23","author":"Movsas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0013","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4","article-title":"Quality of life assessment. An independent prognostic variable for survival in lung cancer","volume":"67","author":"Ganz","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2024.08.010_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(00)00158-4","article-title":"The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy","volume":"55","author":"Langendijk","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2013.06.012","article-title":"Quality of life (QOL) analysis of the randomized radiation (RT) dose-escalation NSCLC trial (RTOG 0617): the rest of the story","volume":"87","author":"Movsas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2024.08.010_bib0016","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1200\/JCO.2009.23.7420","article-title":"Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non\u2013small-cell lung cancer: an analysis of RTOG 9801","volume":"27","author":"Movsas","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0017","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.010_bib0018","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(12)70139-0","article-title":"Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)","volume":"13","author":"Atagi","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424001827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424001827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T23:47:29Z","timestamp":1732319249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730424001827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525730424001827"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2024.08.010","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Untapping the Prognostic Value of Patient-Generated Health Data in Locally Advanced Non-small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}